Response to "Critical Analysis of Apixaban Dose Adjustment Criteria"

Clin Appl Thromb Hemost. 2022 Jan-Dec:28:10760296221078841. doi: 10.1177/10760296221078841.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Pyrazoles*
  • Pyridones*

Substances

  • Pyrazoles
  • Pyridones
  • apixaban